Key Highlights
- L'Oréal increased its stake in Galderma to 20% by purchasing 24 million additional shares.
- The deal is part of L'Oréal's strategy to focus on injectables and science-based skincare technologies.
- L'Oréal shares experienced a decline of almost 1.5% following the announcement.
- Galderma's shares rose nearly 2% after the news broke.
- The purchase price for the additional shares has not been disclosed.
